FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2180-2182 May 15, 2008 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Turner, E. H. PubMed Citation

To the Editor: The importance of the study reported by Turner et al. (Jan. 17 issue),¹ on selective publication of antidepressant trials, can hardly be overstated because it shows how researchers and clinicians are deprived of accurate data, resulting in a wrong understanding of antidepressant efficacy. The most serious implication of this study is that guidelines for the treatment of depression may be inaccurate, since they are often based on meta-analyses of published data alone.^2,3

This current system makes it impossible for scientific journals to provide a valid picture of the efficacy of antidepressants. Therefore, we propose that meta-analyses be . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.